Novavax and Serum Institute of India Receive Emergency Use Aut... - 29 December 2021 02:24

GAITHERSBURG, Md. and PUNE, India, Dec. 29, 2021 /PRNewswire-AsiaNet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by v...

  2020 Global Survey from ISAPS Sees Significant Changes in Aest... - 28 December 2021 23:00

WEST LEBANON, N.H., Dec. 28, 2021 /PRNewswire-AsiaNet/ -- - COVID-19 practice closures lead to a 10.9% decrease in surgical procedures The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, which showc...

  Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory... - 28 December 2021 01:46

SEOUL, South Korea, Dec. 27, 2021 /PRNewswire-AsiaNet/ -- - Lunit meets MDSAP requirements as a global standard medical AI software manufacturer - QMS audit exemption in the US, Canada, Japan, Australia, and Brazil Lunit, a leading AI software company for cancer screening and treatment, announced ...

  Luye Pharma Releases Top-Line Results from a Phase II Clinical... - 23 December 2021 20:08

CHONGQING, China, Dec. 23, 2021 /PRNewswire-AsiaNet/ -- - Showing a comprehensive antidepressant efficacy and a good safety profile without an impact on sexual function Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofax...

  Novavax Announces Initial Omicron Cross-Reactivity Data from C... - 23 December 2021 09:26

GAITHERSBURG, Md., Dec. 23, 2021 /PRNewswire-AsiaNet/ -- - Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants - Third dose produced increased immune responses comparable to or exceeding levels associated with protection ...

  Angel Yeast Invests in New Enzyme Project Capable of 5,000 Ton... - 22 December 2021 23:21

YICHANG, China, Dec. 22, 2021 /PRNewswire-AsiaNet/ -- Angel Enzyme Preparation (Yichang) Co., Ltd., ("Angel Enzyme Preparation"), a wholly-owned subsidiary of Angel Yeast Co., Ltd.( https://en.angelyeast.com/ ), is well underway with construction on its new green manufacturing project in Angel Biotec...

  People-focused Highbrook Medical Centre is Now Officially Open - 22 December 2021 22:42

AUCKLAND, New Zealand, Dec. 22, 2021/PRNewswire-Asianet/-- Highbrook Medical Centre, the newest of Health Improvement Group’s Auckland clinics, including Botany Junction[ https://www.botanyjunctionmedical.co.nz/?utm_source=referral&utm_medium=newswire&utm_campaign=Pressrelease+Highbrook+Medical+Centre...

  World Health Organization SAGE Issues Interim Recommendations ... - 22 December 2021 10:00

GAITHERSBURG, Md., Dec. 22, 2021 /PRNewswire-AsiaNet/ -- - WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older - SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised...

  Karyopharm and Menarini Group Enter into Exclusive License Agr... - 22 December 2021 01:50

NEWTON, Mass. and FLORENCE, Italy, Dec. 21, 2021 /PRNewswire-AsiaNet/ -- - Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries - Karyopharm to Receive $7...

  EVERSANA completes acquisition of Intouch Group, adds the prem... - 22 December 2021 00:32

CHICAGO and KANSAS CITY, Mo., Dec. 22, 2021 /PRNewswire-AsiaNet/ -- EVERSANA(TM) ( https://c212.net/c/link/?t=0&l=en&o=3396142-1&h=2366355774&u=https%3A%2F%2Fwww.eversana.com%2F%3Futm_source%3Dnews%2Brelease%26utm_medium%3Dprnewswire%26utm_campaign%3Deversana_completes_acquisition%2B_intouch%2B_12212021&a=EVERSANA...